These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 15115632

  • 21. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S, Josefsson A, Holmgren J, Harandi AM.
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [Abstract] [Full Text] [Related]

  • 22. Pediatrics and herpes simplex virus vaccines.
    Rupp R, Rosenthal SL, Stanberry LR.
    Semin Pediatr Infect Dis; 2005 Jan; 16(1):31-7. PubMed ID: 15685147
    [Abstract] [Full Text] [Related]

  • 23. Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.
    Awasthi S, Shaw C, Friedman H.
    Expert Rev Vaccines; 2014 Dec; 13(12):1475-88. PubMed ID: 25138572
    [Abstract] [Full Text] [Related]

  • 24. [Natural history of HSV1 and HSV2 infection. Asymptomatic viral excretion. Mother-infant transmission. Indirect transmission].
    Morand P.
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):577-85. PubMed ID: 12122327
    [Abstract] [Full Text] [Related]

  • 25. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR, Heath AW, Jennings R.
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [Abstract] [Full Text] [Related]

  • 26. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
    Tengvall S, O'Hagan D, Harandi AM.
    Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
    [Abstract] [Full Text] [Related]

  • 27. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes.
    Bernstein DI, Pullum DA, Cardin RD, Bravo FJ, Dixon DA, Kousoulas KG.
    Vaccine; 2019 Jan 03; 37(1):61-68. PubMed ID: 30471955
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
    Boukhvalova M, McKay J, Mbaye A, Sanford-Crane H, Blanco JC, Huber A, Herold BC.
    J Virol; 2015 Oct 03; 89(19):9825-40. PubMed ID: 26178984
    [Abstract] [Full Text] [Related]

  • 29. Debate: the argument for. Should all pregnant women be offered type-specific serological screening for HSV infection?
    Kinghorn GR.
    Herpes; 2002 Jul 03; 9(2):46-7. PubMed ID: 12106511
    [Abstract] [Full Text] [Related]

  • 30. Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine.
    Bernstein DI, Aoki FY, Tyring SK, Stanberry LR, St-Pierre C, Shafran SD, Leroux-Roels G, Van Herck K, Bollaerts A, Dubin G, GlaxoSmithKline Herpes Vaccine Study Group.
    Clin Infect Dis; 2005 May 01; 40(9):1271-81. PubMed ID: 15825029
    [Abstract] [Full Text] [Related]

  • 31. [Recurrent genital herpes].
    Holub M, Labská K, Roubalová K.
    Klin Mikrobiol Infekc Lek; 2008 Apr 01; 14(2):52-9. PubMed ID: 18756434
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB, Burke RL, Ghiasi H, Slanina SM, Wechsler SL.
    Virology; 1998 Dec 05; 252(1):200-9. PubMed ID: 9875329
    [Abstract] [Full Text] [Related]

  • 33. Prevention, recognition and management of neonatal HSV infections.
    Robinson JL, Vaudry WL, Forgie SE, Lee BE.
    Expert Rev Anti Infect Ther; 2012 Jun 05; 10(6):675-85. PubMed ID: 22734957
    [Abstract] [Full Text] [Related]

  • 34. Herpes simplex virus in pregnancy: new concepts in prevention and management.
    Hill J, Roberts S.
    Clin Perinatol; 2005 Sep 05; 32(3):657-70. PubMed ID: 16085025
    [Abstract] [Full Text] [Related]

  • 35. Genital herpes complicating pregnancy.
    Brown ZA, Gardella C, Wald A, Morrow RA, Corey L.
    Obstet Gynecol; 2005 Oct 05; 106(4):845-56. PubMed ID: 16199646
    [Abstract] [Full Text] [Related]

  • 36. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.
    Invest Ophthalmol Vis Sci; 2007 Oct 05; 48(10):4643-53. PubMed ID: 17898288
    [Abstract] [Full Text] [Related]

  • 37. Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon.
    Ozouaki F, Ndjoyi-Mbiguino A, Legoff J, Onas IN, Kendjo E, Si-Mohamed A, Mbopi-Kéou FX, Malkin JE, Bélec L.
    Int J STD AIDS; 2006 Feb 05; 17(2):124-7. PubMed ID: 16464276
    [Abstract] [Full Text] [Related]

  • 38. Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay.
    Arvin AM, Prober CG.
    Infect Agents Dis; 1993 Dec 05; 2(6):375-82. PubMed ID: 8012738
    [No Abstract] [Full Text] [Related]

  • 39. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP.
    J Infect Dis; 2005 Feb 01; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [Abstract] [Full Text] [Related]

  • 40. Neonatal herpes simplex virus infection.
    Cherpes TL, Matthews DB, Maryak SA.
    Clin Obstet Gynecol; 2012 Dec 01; 55(4):938-44. PubMed ID: 23090462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.